Standardization of ambulatory peak flow monitoring: The importance of recent β2-agonist inhalation

European Respiratory Journal

Volumn 12, Issue 2, 1998, Pages 309-314

  Reddel, H K ^a,b   Ware, S I ^a   Salome, C M ^a   Marks, G B ^a   Jenkins, C R ^a   Woolcock, A J ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Asthma; Bronchodilator agents; Clinical protocols; Peak expiratory flow rate

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; HISTAMINE; SALBUTAMOL; TERBUTALINE;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; OUTCOMES RESEARCH; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; SPIROMETRY; STANDARDIZATION;

EID: 0031815997     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12020309     Document Type: Article

References (22)

1. The British Thoracic Society, The National Asthma Campaign and The Royal College of Physicians of London in association with the General Practitioner in Asthma Group, The British Association of Accident and Emergency Medicine, The British Paediatric Respiratory Society and the Royal College of Paediatric and Child Health. 1995 Review and Position statement. Thorax 1996; 52: Suppl. 1, S1-S21.
2. GINA (Global initiative for asthma). Asthma management and prevention, NIH Publication No. 96-3659A. Bethesda, MD, NHLBI, 1995.
3. NAEPP Expert Panel Report 2. Guidelines for the diagnosis and management of asthma, NIH Publication No. 97-4051. Bethesda, MD, NHLBI, 1997.
4. Quackenboss JJ, Liebowitz MD, Krzyzanowski M. The normal range of diurnal changes in peak expiratory flow rates Relationship to symptoms and respiratory disease. Am Rev Respir Dis 1991; 143: 323-330.
5. van Aalderen WM, Postma DS, Koëter GH, Knol K. The effect of reduction of maintenance treatment on circadian variation in peak expiratory flow rates in asthmatic children. Acta Paediatr Scand 1988; 77: 269-274.
6. Beasley R, Cushley M, Holgate ST. A self-management plan in the treatment of adult asthma. Thorax 1989; 44: 200-204.
7. Reddel HK, Ware SI, Salome CM, et al. Pitfalls in processing electronic spirometric data in asthma. Eur Respir J 1998; 12: (in press).
8. Enright PL, Lebowitz MD, Cockroft DW. Physiologic measures: pulmonary function tests. In: NIH Workshop on measures for use in asthma clinical research. Am J Respir Crit Care Med 1994; 149: S1-S8.
9. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
10. Britton J. Measurement of peak flow variability in community populations: methodology. Eur Respir J 1997; 10: Suppl. 24, 42s-44s.
11. Gannon PFG, Burge PS. Serial peak expiratory flow measurement in the diagnosis of occupational asthma. Eur Respir J 1997; 10: Suppl. 24, 57s-63s.
12. Yan K, Salome CM, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax 1983; 38: 760-765.
13. Reddel HK, Salome CM, Peat JK, Woolcock AJ. Which index of peak expiratory flow is most useful in the management of stable asthma? Am J Respir Crit Care Med 1995; 151: 1320-1325.
14. Brand P, Duiverman E, Postma D, et al. Peak flow variation in childhood asthma: relationship to symptoms, atopy, airways obstruction and hyperresponsiveness. Eur Respir J 1997; 10: 1242-1247.
15. Bland JM, Altman DG. Statistical method for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307-310.
16. Green DM, Swets JA. Signal Detection Theory and Psychophysics, Rev. Edn. Huntington, NY, USA, Krieger, 1974.
17. Marks GB, Mellis CM, Peat JK, et al. A profile of asthma and its management in a New South Wales provincial centre. Med J Aust 1994; 160: 260-268.
18. Cockcroft DW. Asthma control versus asthma severity. J Allergy Clin Immunol 1996; 98: 1016-1018.
19. Toogood JH, Andreaou P, Baskerville J. A methodological assessment of diurnal variability of peak flow as a basis for comparing different inhaled steroid formulations. J Allergy Clin Immunol 1996; 98: 555-562.
20. Di Matteo M. Enhancing patient adherence to medical recommendations. JAMA 1994; 271: 79-83.
21. Rand C, Wise R, Adherence with asthma therapy in the management of asthma: review and clinical guidelines. In: Szefler S, Leung D, eds. Severe Asthma: Pathogenesis and Clinical Management. New York, Marcel Dekker, 1995; pp. 435-464.
22. DiMatteo MR, Hays RD, Gritz ER, et al. Patient adherence to cancer control regimens: scale development and initial validation. Psychol Assess 1993; 5: 102-112.